Literature DB >> 2425433

A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles.

F Delpeyroux, N Chenciner, A Lim, Y Malpièce, B Blondel, R Crainic, S van der Werf, R E Streeck.   

Abstract

The hepatitis B virus (HBV) envelope protein carrying the surface antigen (HBsAg) is assembled with cellular lipids in mammalian cells into empty viral envelopes. In a study to evaluate the capacity of such particles to present foreign peptide sequences in a biologically active form, in-phase insertions were created in the S gene encoding the major envelope protein. One of the sequences inserted was a synthetic DNA fragment encoding a poliovirus neutralization epitope. Mammalian cells expressing the modified gene secreted hybrid particles closely resembling authentic 22-nanometer HBsAg particles. These particles reacted with a poliovirus-specific monoclonal antibody and induced neutralizing antibodies against poliovirus. The results indicate that empty viral envelopes of HBV may provide a means for the presentation of peptide sequences and for their export from mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425433     DOI: 10.1126/science.2425433

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

1.  Identification of immunogenic hot spots within plum pox potyvirus capsid protein for efficient antigen presentation.

Authors:  M Rosario Fernández-Fernández; Jorge L Martínez-Torrecuadrada; Fernando Roncal; Elvira Domínguez; Juan Antonio García
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles.

Authors:  R Prange; R Nagel; R E Streeck
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Mutational analysis of hepatitis B surface antigen particle assembly and secretion.

Authors:  V Bruss; D Ganem
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses.

Authors:  Andrés Báez-Astúa; Elsa Herráez-Hernández; Natalio Garbi; Hilda A Pasolli; Victoria Juárez; Harald Zur Hausen; Angel Cid-Arregui
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 5.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

6.  Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles.

Authors:  F Delpeyroux; E Van Wezel; B Blondel; R Crainic
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

Review 7.  Gene vaccination for hepatitis C.

Authors:  G Inchauspé
Journal:  Springer Semin Immunopathol       Date:  1997

8.  Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode.

Authors:  I Nakano; G Maertens; M E Major; L Vitvitski; J Dubuisson; A Fournillier; G De Martynoff; C Trepo; G Inchauspe
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

Review 9.  Prospects for vaccines against HIV.

Authors:  A J Zuckerman
Journal:  BMJ       Date:  1988-07-09

10.  Immunological properties of hepatitis B core antigen fusion proteins.

Authors:  M J Francis; G Z Hastings; A L Brown; K G Grace; D J Rowlands; F Brown; B E Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.